Dr. Debora Santos Bruno, MD

Dr. Bruno practices at City of Hope Cancer Center Atlanta in Newnan, Georgia, part of City of Hope.

Dr. Bruno's NPI, 1437100302, was assigned on May 15, 2006. Dr. Bruno holds Nebraska license 23664.

Dr. Bruno's primary practice is City of Hope Cancer Center Atlanta, at 600 Celebrate Life Parkway North, Newnan, GA 30265 in Coweta County. The practice phone is (404) 844-8334.

Dr. Bruno's primary practice is City of Hope Cancer Center Atlanta in Newnan, Georgia, part of City of Hope. The medical group on file is City of Hope Atlanta. Dmand AI also links Dr. Bruno to 2 more medical groups, each named with a free account. Dr. Bruno's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bruno practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Bruno's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Bruno is licensed in Nebraska.

CMS data shows 250 Medicare services from Dr. Bruno across 4 procedure codes in 2024, all of them office visits, for 93 Medicare patients. Medicare paid $21,153 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 93 Medicare patients who saw Dr. Bruno in 2024. The largest group is 65 to 74, with 45 patients. 75% of them have cancer, and 75% have high blood pressure. 14% are also on Medicaid. Their average risk score is 2.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bruno's median patient age at 70, with 63% women.

In 2024, Dr. Bruno wrote 727 Medicare Part D claims for 93 patients. 78% of them were for generic drugs. CMS names the drug for 541 of them, across 15 drugs with 11 or more claims each, at $1,364,182 in total drug cost. In 2023, CMS named 435 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Bruno for performance year 2024, reported as part of a group. Dr. Bruno accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bruno as offering telehealth.

CMS Open Payments shows 69 general payments to Dr. Bruno from 14 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 78% of the total. AstraZeneca Pharmaceuticals LP paid the most, $17,697.